Login / Signup

Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma.

Shuanzeng WeiJianming PeiPaul BelserTeresa LeeJeffrey M FarmaArthur S PatchefskyDouglas B FliederElizabeth A Montgomery
Published in: Genes, chromosomes & cancer (2024)
Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor PLAG1 fusions (TRPS1::PLAG1, RAD51B::PLAG1, and TRIM13::PLAG1). In this report, we present a case of rectal MLS with a novel MIR143HG::PLAG1 fusion detected by RNA next-generation sequencing.
Keyphrases
  • poor prognosis
  • long non coding rna
  • cell proliferation
  • rectal cancer
  • soft tissue
  • long noncoding rna
  • copy number
  • dna damage
  • gene expression
  • genome wide identification